Ovid's Jeremy Levin on advances in CNS, soticlestat, ROCK2, Washington and more
Jeremy Levin walks us through the science of Ovid's CNS-focused pipeline, gives his take on the health of the biotech, and why it is important to not let populism drag the sector down.